Bellecapital International Ltd. Iovance Biotherapeutics, Inc. Transaction History

Bellecapital International Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 14, 2021	SELL	$28.04 - $50.26 $194,261 - $348,201	-6,928 Closed	0 $0
Q3 2020 Oct 16, 2020	BUY	$27.75 - $36.3 $192,252 - $251,486	6,928 New	6,928 $228,000
Q2 2020 Jul 16, 2020	SELL	$27.21 - $41.0 $188,510 - $284,048	-6,928 Closed	0 $0
Q1 2020 Apr 24, 2020	BUY	$19.54 - $38.85 $135,373 - $269,152	6,928 New	6,928 $207,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.